2017 Annual Meeting

Association for Molecular Pathology

March 5 2017, 7:30pm to 10:30pm


Association for Molecular Pathology

Lessons Learned in Molecular Oncology

Sunday, March 5, 2017
7:30 PM 10:30 PM
CC 304

Session Credits: 3 CME and SAMs

Moderators: Cecilia Yeung, MD, Fred Hutchinson Cancer Research Center, Seattle WA
James R. Cook, MD, PhD, Cleveland Clinic and Case Western Reserve University Cleveland, OH

Course Description:
Molecular diagnostic assays play an increasingly important role in the diagnosis, classification, and prognostic assessment of cancer, as well as in guiding the selection of treatment modalities. Keeping up with the rapid pace of new discoveries in molecular oncology creates numerous practical challenges for surgical pathologists and molecular diagnostic laboratories alike.

In this session, speakers will address the current standard of molecular diagnostic practice in selected aspects of hematolymphoid, pulmonary, and gastrointestinal pathology. Speakers will be selected to represent knowledgeable individuals in these fields, and to provide a cross-section of perspectives including academic molecular pathology laboratories, reference laboratories, and the surgical pathologists and hematopathologists who must integrate results of molecular diagnostic assays into their final pathology reports.

Each speaker will be asked to address a specific challenge faced in their practice, and the steps they took to address these challenges. Possible examples include: the choice of analytes to be tested; selection of appropriate methodologies; integration of multiple modalities, such as sequencing, FISH, and arrays; balancing standard of care and research needs; expanding informatics infrastructure; appropriate formatting of reports and integration with surgical pathology results; hurdles to billing and reimbursement.

Upon completion of this educational activity, participants should be better able to:

  • Describe current standards of molecular diagnostic practice in lung, gastrointestinal, and hematolymphoid cancers
  • Identify appropriate molecular diagnostic methodologies and challenges in the health system environment
  • Measure differences in clinical practice based on molecular diagnostic reporting and interpretation


7:30 PM

Welcome and Introduction
James R. Cook, MD, PhD, Cleveland Clinic, and Case Western Reserve University, Cleveland, OH

7:45 PM

Molecular Studies in Lung Cancer
Neal I. Lindeman, MD, Brigham & Women’s Hospital, Harvard Medical school, Boston, MA

8:15 PM

Molecular Studies in GI Pathology
Antonia R. Sepulveda, MD, PhD, Columbia University Medical Center, New York, NY

8:45 PM

Molecular Studies in Myeloid Neoplasms
Todd W. Kelley, MD, University of Utah and ARUP Laboratories, Salt Lake City, UT

9:15 PM

Future Directions and Panel Q & A
Cecilia C.S. Yeung, MD, Fred Hutchinson Cancer Research Center, Seattle, WA


view more